EVANS BARRETT enters PROTAGENIC THERAPEUTICS, INC.\NEW with 154.55K shares across direct and indirect positions
This filing by EVANS BARRETT (ex CEO) establishes the baseline for all future Form 4 insider transaction reports at PROTAGENIC THERAPEUTICS, INC.\NEW.
Direct Indirect
Filed: 10/24/2025ACC: 0001096906-25-001711
DirectorOfficer10% Owner· ex CEO
Since May 2025
154.55K
Baseline shares
1% direct
1K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
6
Security positions
153.55K indirect
Non-Derivative Holdings6
Common Stock
IndirectShares owned16.23K
Preferred Stock Series C
IndirectShares owned787.00
Preferred Stock Series D
DirectShares owned1K
Preferred Stock Series C-1
IndirectShares owned131.03K
Preferred Stock Series D
IndirectShares owned1K
Preferred Stock Series D
IndirectShares owned4.50K
Total
1K direct·153.55K indirect154.55K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.23K | Indirect |
| Preferred Stock Series C | 787.00 | Indirect |
| Preferred Stock Series D | 1K | Direct |
| Preferred Stock Series C-1 | 131.03K | Indirect |
| Preferred Stock Series D | 1K | Indirect |
| Preferred Stock Series D | 4.50K | Indirect |
| Total | 154.55K | 1K direct·153.55K indirect |
Derivative Holdings0
No derivative holdings reported